Phase 3 Clinical Trials With Primary Completion Dates in September 2021

This is a list of Phase 3 trials with primary completion dates in September 2021 for companies with a market cap less than $1B. For complete clinical trial coverage, please see our Trial Tracker tool. It includes information on all clinical trials for publicly traded companies, screenable by stock symbol, market cap, disease, completion date, and phase.

The primary completion date is the date that the final subject was examined or received an intervention for the purposes of final collection of data for the primary outcome. It provides advance notice that a company will be announcing trial results in the near future.

SymbolCompanyPrimary Completion DatePhaseNCT IDTitle
ACADACADIA Pharmaceuticals Inc.2021-09-01Phase 3NCT04181723Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDERâ„¢)
AGLEAeglea BioTherapeutics, Inc.2021-09-01Phase 3NCT03921541Efficacy and Safety of Pegzilarginase in Patients With Arginase 1 Deficiency
ANGNAngion Biomedica Corp.2021-09-01Phase 3NCT02474667Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney
APLIFAppili Therapeutics Inc.2021-09-01Phase 3NCT04600895The Prevent Severe COVID-19 (PRESECO) Study
BBIBrickell Biotech, Inc.2021-09-01Phase 3NCT03948646Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-302)
FOLDAmicus Therapeutics, Inc.2021-09-01Phase 3NCT03911505ZIP Study - A Study of the Safety, Pharmacokinetics, Efficacy, Pharmacodynamics, and Immunogenicity of ATB200/AT2221 in Pediatric Subjects Aged 0 to < 18 Years With Pompe Disease
NBIXNeurocrine Biosciences, Inc.2021-09-01Phase 3NCT04102579Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Chorea Associated With Huntington Disease
NEPHNephros, Inc.2021-09-01Phase 3NCT02757872Effects of Vitamin D and Fish Oil on the Kidney in Hypertensives
PYPDPolyPid Ltd.2021-09-01Phase 3NCT04233424D-PLEX 311: Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection
PYPDPolyPid Ltd.2021-09-01Phase 3NCT03558984D-PLEX 302: Efficacy and Safety of D-PLEX in the Prevention of Sternal Infection Post Cardiac Surgery
RDUSRadius Health, Inc.2021-09-01Phase 3NCT04064411Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis
SCYXSCYNEXIS, Inc.2021-09-01Phase 3NCT04029116Phase 3 Study of Oral Ibrexafungerp (SCY-078) Vs. Placebo in Subjects With Recurrent Vulvovaginal Candidiasis (VVC)
SCYXSCYNEXIS, Inc.2021-09-01Phase 3NCT03059992Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment
VNDAVanda Pharmaceuticals Inc.2021-09-01Phase 3NCT04028492Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis
XFORX4 Pharmaceuticals, Inc.2021-09-01Phase 3NCT03995108Efficacy and Safety Study of Mavorixafor in Participants With Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) Syndrome